Browsing by Author Collado, Rosa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2017A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
2015A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
2018Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients.
2016-12-06Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
2015-12-03Molecular Response at 3 Months Measured with Genexpert BCR-ABL (IS) Platform Predicts Further Outcome in Chronic Myeloid Patients but the Cutoff Differs from the 10% Commonly Used with BCR-ABL (IS) EUTOS Method
Garcia-Gutierrez, Valentin; Gomez Casares, Maria Teresa; Velasco Antonio, Jimenez; Juan Manuel, Alonso; Osorio, Santiago; Carlos Hernandez-Boluda, Juan; Manuel Puerta, Jose; Collado, Rosa; Jose Ramirez, Maria; Ibaaez, Fatima; Martin Mateos, Maria Luisa; Rodriguez Gambarte, Juan Diego; Martinez Laperche, Carolina; Redondo, Sara; Gomez, Montse; Suarez Fiallo, D. V.; Rodriguez Fernandez, Alicia; Ruiz, Concepcion; Luis Steegmann, Juan; [Garcia-Gutierrez, Valentin] Hosp Ramon & Cajal, Dept Hematol, E-28034 Madrid, Spain; [Gomez Casares, Maria Teresa] Hosp Univ Doctor Negrin, Dept Hematol, Las Palmas De Gran Canai, Spain; [Velasco Antonio, Jimenez;Ruiz, Concepcion] Hosp Reg Univ Malaga, Serv Hematol, Malaga, Spain; [Juan Manuel, Alonso] Hosp Infanta Sofia, Lab Cent Br Salud, Madrid, Spain; [Osorio, Santiago;Martinez Laperche, Carolina;Redondo, Sara] Hosp Univ Gregorio Maranon, Serv Hematol, Madrid, Spain; [Carlos Hernandez-Boluda, Juan;Gomez, Montse] Hosp Clin, Dept Hematol, Valencia, Spain; [Manuel Puerta, Jose] Hosp Univ Virgen de las Nieves, Unidad Gest Clin Hematol & Hemoterapia, Granada, Spain; [Collado, Rosa] Consorcio Hosp Gen Univ, Serv Hematol, Genet Lab, Valencia, Spain; [Jose Ramirez, Maria] Hosp Jerez de la Frontera, Dept Hematol, Jerez De La Frontera Cad, Spain; [Ibaaez, Fatima;Martin Mateos, Maria Luisa] Hosp San Pedro Alcantara, Serv Extremeno Salud, Serv Hematol, Caceres, Spain; [Rodriguez Gambarte, Juan Diego] Hosp Univ Ramon y Cajal, Dept Hematol, Madrid, Spain; [Suarez Fiallo, D. V.] Hosp Univ Doctor Negrin, Dept Hematol, Las Palmas Gran Canaria, Spain; [Rodriguez Fernandez, Alicia] Hosp Virgen de la Macarena, Serv Hematol, Seville, Spain; [Luis Steegmann, Juan] Hosp Univ Princesa, Inst Invest Sanitaria, Madrid, Spain
2017-08-15Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions.